Abbott · 1 day ago
Director, Biocompatibility
Abbott is a global healthcare leader that helps people live more fully at all stages of life. The Director of Biocompatibility is responsible for providing strategic leadership and scientific direction for the global biocompatibility and materials safety program supporting medical devices and combination products.
BiotechnologyEmergency MedicineGeneticsHealth CareHealth DiagnosticsManufacturingMedicalMedical DeviceNutritionPharmaceutical
Responsibilities
Develop and execute the global biocompatibility strategy aligned with business and regulatory objectives
Provide scientific and regulatory leadership on biological safety and toxicological risk assessment for materials, manufacturing processes, and finished products
Integrate biocompatibility considerations early in product design, development, and lifecycle management
Lead and mentor teams of biocompatibility scientists across multiple sites
Foster a culture of collaboration, accountability, and continuous improvement
Oversee capacity planning, resource allocation, and performance management within the biocompatibility organization
Ensure compliance with ISO 10993 and applicable global regulatory guidance
Provide expert input for regulatory submissions (IDE, PMA, 510(k), CE, NMPA, etc.) and represent the function during audits and agency interactions
Maintain strong awareness of evolving global biocompatibility and toxicology regulations and guide the organization in adapting accordingly
Oversee biological evaluation plans, toxicological risk assessments, and testing strategies for medical devices and combination products
Collaborate closely with R&D, Quality, Regulatory, and Manufacturing to ensure material and process changes are biologically safe
Guide biological evaluation programs for complex devices and combination products
Partner with materials science, chemistry, and analytical testing teams to establish integrated strategies for material characterization and safety
Serve as a key advisor to product development teams to enable safe, compliant, and efficient product launches
Engage with external experts and standards organizations to influence future regulatory and technical frameworks
The position interacts directly with functional groups including R&D groups, Preclinical, Regulatory, Analytical Chemistry, and Quality groups in the Abbott various business Divisions and CROs
Qualification
Required
Bachelor's degree required
Ph.D. or M.S. required in Biology, Biomedical Engineering, Materials Science, Toxicology, or related discipline, preferably with a specialism relating to medical devices
Minimum of 15+ years of relevant experience required in biocompatibility, toxicology, or materials safety within the medical device or combination product
Minimum of 10 years of leadership experience, including managing scientific teams and cross-site functions
Proven record of leading global biocompatibility or toxicology programs supporting regulatory submissions and product approvals
Expert in US and global regulations (e.g., EU, China, Korea and Japan) and requirements for biocompatibility and safety testing, particularly ISO 10993
Strong understanding of extractables and leachables, chemical characterization, and toxicological risk assessment methodologies
Excellent scientific judgment and strategic thinking
Exceptional communication, collaboration, and influencing skills
Demonstrated ability to lead in a global organization
Preferred
Regulatory interaction experience (FDA, notified bodies, etc.) strongly preferred
Benefits
Free medical coverage in our Health Investment Plan (HIP) PPO medical plan
An excellent retirement savings plan with high employer contribution
Tuition reimbursement
The Freedom 2 Save student debt program
FreeU education benefit - an affordable and convenient path to getting a bachelor’s degree
Company
Abbott
Abbott is a healthcare company that produces diagnostic kits, medical devices, nutritional products, and branded generic medicines.
Funding
Current Stage
Public CompanyTotal Funding
$6.79M2011-03-15Post Ipo Debt· $0.1M
2009-03-16Post Ipo Debt· $6.69M
1980-12-12IPO
Recent News
2026-01-07
2025-12-31
Company data provided by crunchbase